常规折扣通常是证明问题和激励问题，几乎不是费率问题。 适用于会计事务所的这个问题版本不是通用的。合规费用压缩，无法在不减少法定产出的情况下将工时转向咨询，因此忽略82%实现率的答案会自信地错误。分析必须从71%计费利用率和34%咨询中标率开始，而不是从收入开始。
常规折扣通常是证明问题和激励问题，几乎不是费率问题。 适用于会计事务所的这个问题版本不是通用的。合规费用压缩，无法在不减少法定产出的情况下将工时转向咨询，因此忽略82%实现率的答案会自信地错误。分析必须从71%计费利用率和34%咨询中标率开始，而不是从收入开始。
当折扣成为常态，有效收费已被重置为折扣水平，报价费率只是装饰。这除了毛利之外还有成本：它告诉市场你实际通过实现率能收回多少，而且很难逆转。
原因一致。价值未被证明，所以费用成为唯一可讨论的变量。或者合伙人激励以计费工时而非毛利为导向，此时折扣正是理性行为。或者实现率裁量权不受限，而不受限的裁量权总会被使用。
诊断在于分布。如果实现率在期末或特定合伙人处集中，原因就是激励和权限，而非费率。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 实现率在最后几周因在建工程减记以结账而急剧下降。
✓ 类似合规项目上，不同合伙人实现率差异很大。
✓ 合伙人要求减记权限，而不是证明咨询价值的支撑。
通常会让情况更糟的做法。 降低标准费率以反映现实，这会重置锚点，并在两个季度内产生新费率下的相同减记。
It is for you if you run or finance an accounting firm and discounts spike at period end. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家会计事务所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Pennmark Advisory, a sample company profile used for testing rather than a customer — 43.2m total revenue with 210 fte staff.
Excerpt from a real Percision run · Customer Value Architecture · sample company profile
The move. Convert 15,000 compliance hours into $1.9M incremental EBITDA by embedding advisory inside existing client relationships.
| Investment required | $0.8M-$1.2M for 6 FTE conversion specialists (salary + training); funded entirely from existing $7.8M EBITDA within 24-month payback constraint |
| Expected return | Base case: $1.9M incremental EBITDA on $1.0M investment = 1.9× return within 24 months; Low case: $1.4M EBITDA (26% lower pipeline conversion); High case: $2.4M EBITDA (26% higher win rate) |
| Revenue, year 1 | $0.6M incremental advisory revenue (partial year, 6 specialists hired Q2 2027) |
| Revenue, year 2 | $1.9M incremental EBITDA (full-year run rate) |
| Revenue, year 3 | $2.8M incremental EBITDA (additional 4 specialists funded by Year 2 cash flow) |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) advisory win rate falls below 25% for two consecutive quarters, OR (b) compliance retention drops below 88%, OR (c) incremental EBITDA from conversion specialists fails to reach $800K annual run-rate by Month 18 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 定价与收入优化, one of 29 engagements the platform runs. For 会计事务所 it works through 82% realisation rate, 71% billable utilisation, 34% advisory win rate and 91% compliance client retention, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
限制裁量权，按毛利而非收入支付。折扣是对以收入计量配额且附无限定价权的理性回应。
不是——作为有意的、有结构的交换以获得你想要的东西，如条款、量或推荐。作为谈判结束时的反射，它是无偿让出的毛利。
续约时提前通知并说明理由进行调整，并接受部分客户会离开。替代方案是永久的两级价格，最终会被其余市场发现。
Materially, yes. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82% realisation rate, 71% billable utilisation, 34% advisory win rate, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82% realisation rate and 71% billable utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית